Evidence map›Paper›PMID 41729450›Full record

ArticleJournal of autism and developmental disorders2026

Age-Specific Patterns in Utilization and Costs of Developmental Rehabilitation Therapy for Children With Autism Spectrum Disorder in South Korea: A Cross-Sectional Survey.

Jeong-Hyeon Park, Seong-Jung Kim, Sung Ja Cho, Sun-Hong Kwon, Dong-Won Kang, Eui-Kyung Lee

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of autism and developmental disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jeong-Hyeon ParkSchool of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon-si, Gyeonggi-do, 16419, Republic of Korea.ORCID http://orcid.org/0009-0009-6834-1921
Seong-Jung KimSchool of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon-si, Gyeonggi-do, 16419, Republic of Korea.ORCID http://orcid.org/0009-0003-9576-1135
Sung Ja ChoNeudive Inc, Daegu, Republic of Korea.ORCID https://orcid.org/0000-0001-9673-6976
Sun-Hong KwonSchool of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon-si, Gyeonggi-do, 16419, Republic of Korea.ORCID https://orcid.org/0000-0002-1058-8392
Dong-Won KangCollege of Pharmacy, Ajou University, 206 World cup-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea. dwonkang@ajou.ac.kr.ORCID https://orcid.org/0000-0002-7088-867X
Eui-Kyung LeeSchool of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon-si, Gyeonggi-do, 16419, Republic of Korea. ekyung@skku.edu.ORCID https://orcid.org/0000-0003-0601-7754

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study examined age-specific utilization patterns and costs of developmental rehabilitation therapy among children with autism spectrum disorder (ASD) in South Korea.

methodsA cross-sectional online survey was conducted in November 2024 among caregivers of children under 18 years with ASD. Participants were recruited via online communities for caregivers of children with ASD. Quota sampling was employed to categorize respondents into four age groups (≤ 6, 7–9, 10–12, and ≥ 13 years) based on school age. Only those whose children had received developmental rehabilitation therapy within the past three months were included. Therapy type, frequency, and monthly costs were assessed. Generalized linear models with a gamma distribution were used to identify factors associated with total and out-of-pocket costs.

resultsData from 144 children with ASD were analyzed. Children aged 7–12 received the widest range of therapies, whereas adolescents ≥ 13 years received the fewest. Applied Behavior Analysis, the costliest therapy, was most frequently used among children ≤ 6 years. This youngest group also incurred the highest monthly costs (total: US$682.6; out-of-pocket: US$557.7), despite the lowest proportion of government voucher support (7.1%). Younger age and greater disability severity were associated with higher expenditures. Financial burden was the most common reason for planned therapy discontinuation.

conclusionDevelopmental rehabilitation therapy for ASD shows marked age-related differences in utilization and financial burden. Younger children, particularly those ≤ 6 years, receive more intensive and costly therapies but have the lowest public support. Targeted policy interventions are needed to improve access and reduce the financial burden across age groups.

Indexed as

Autism spectrum disorderCross-sectional surveyDevelopmental rehabilitationHealth care access

Identifiers

PMID41729450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.